Science | Page 10 of 29

Sanofi and Google Life Sciences to Collaborate to Improve Diabetes Health Outcomes

Sanofi and the Google life sciences team announced that they are collaborating to improve care and outcomes for people with type 1 and type 2 diabetes. The collaboration will pair Sanofi's leadership in diabetes treatments and devices with Google's expertise in analytics, miniaturized electronics and low power chip design.

Diabetes Vaccine: New Treatment Attacks Diabetes Before it Starts

Is the best way to beat type 1 diabetes to simply stop it before it starts? That’s a question being tackled in new clinical trial that proposes to prevent diabetes in those prone to developing it. “Often times, the best answer is the simple answer,” says Ezio Bonifacio, Ph.D., from the Center for Regenerative Therapies, in Dresden, who led a team of researchers to develop a vaccine to prevent type 1 diabetes. The vaccine has ended up being insulin itself.

Smart Insulin Patch Holds Promise for Treating Diabetes

The penny-sized patch is embedded with more than one hundred tiny needles, each about the width and length of an eyelash. Those needles in turn are loaded with microscopic storage units containing insulin and glucose-sensing enzymes that trigger a release of insulin when blood sugar levels go past a certain level.

Why I Became a Diabetes Researcher

While the drug I worked on at UVA did not prevent or reverse the onset of diabetes, I have continued to study what initiates the development of Type 1 diabetes and how we might be able to stop it. Fueled by my desire to help Katherine, I am working with a team of other scientists from around the world to determine whether or not viruses might play a role in Type 1 diabetes development.

Report from ADA: How Far Diabetes Care Has Come, And How Far We Still Have to Go

Both type 1 and type 2 are on the rise: since 1985 the number of people with diabetes worldwide has increased ten-fold, from 35 million to 371 million; and it’s projected to double again over the next two decades.

Helmsley Type 1 Diabetes Program Announces $5M Request for Proposals

The Type 1 Diabetes Program of The Leona M. and Harry B. Helmsley Charitable Trust has announced the launch of the Diabetes Data Innovation Initiative through which it will provide up to $5 million in funding over the next two years. The funding will go to innovative solutions that enable the use of data to ease the burden of type 1 diabetes (T1D) for those living with the disease, their caregivers and healthcare providers.

Could Reversing Inflammation Cure Diabetes?

Scientists have successfully reversed type 1 diabetes in mice by using adult stem cells and cell surface molecular engineering to reduce the destruction of insulin-producing islet cells. The key to the breakthrough was introducing adult stem cells...

Researchers Aim to Stop Type 1 Diabetes Before it Starts

Researchers with the Janssen Pharmaceutical Companies of Johnson & Johnson recently announced a plan to prevent type 1 diabetes by intercepting the disease in its earliest stages and stopping its development before the onset of symptoms.

Researchers Create Smart Insulin that Reacts to Glucose Levels

Researchers at MIT successfully tested an engineered “smart insulin” on mice that reacts to blood sugar levels. “To make insulin that is…

JDRF and Janssen Team Up to Intercept Type 1 Diabetes

Janssen Research & Development, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced that it will invest in a novel scientific approach, called disease interception, to find ways to intercept type 1 diabetes using new diagnostic and pre-disease intervention strategies. If successful, this approach has the potential to transform the standard of care in type 1 diabetes.